2-(Bromomethyl)-3,5-difluoropyridine

Catalog No.: 
ACAIXO095
CAS No.: 
1227516-28-0
Molecular Formula: 
C6H4BrF2N
Molecular Weight: 
208.01
2-(Bromomethyl)-3,5-difluoropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$203.00InquiryInquiry
250mg95%$382.00InquiryInquiry
1g95%$1497.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Bromomethyl)-3,5-difluoropyridine
IUPAC Name2-(bromomethyl)-3,5-difluoropyridine
MDL No.MFCD11520702
Molecular FormulaC6H4BrF2N
Molecular Weight208.01
SMILESFC1C=C(F)C(CBr)=NC=1
InChI KeyKYLLSIJJZYPFIN-UHFFFAOYSA-N
SynonymPyridine, 2-(broMoMethyl)-3,5-difluoro-;2-BroMoMethyl-3,5-difluoropyridine
CAS No.1227516-28-0

Safety Data

Pictogram
CorrosiveFlammableHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H226-H302-H314
Precautionary Statement(s)
P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P403+P235

Synthetic Route by SureRoute

1. ACAIXO095 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTSEA273 route compound structure diagram
    ACTSEA2731065267-14-2In Stock
  4. Then
  5. ACAIXO095 route product structure diagram
    ACAIXO0951227516-28-0
Inquiry

2. ACAIXO095 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXHFV067 route compound structure diagram
    ACXHFV067780801-58-3In Stock
  4. Then
  5. ACAIXO095 route product structure diagram
    ACAIXO0951227516-28-0
Inquiry

3. ACAIXO095 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAIXO095 route product structure diagram
    ACAIXO0951227516-28-0
Inquiry

Comments (0)